glp-1 препараты Агонисты рецепторов глюкагоноподобного пептида (ГПП) - список препаратов из 15.03 входит в группу клинико-фармакологических указателей (КФУ) 15 Троянский конь» для похудения: новый

While absolute muscle mass and strength decrease, relative muscle mass and strength improve, resulting in better running performance

Sustainable weight maintenance after Zepbound requires permanent lifestyle modifications rather than temporary dietary changes

It belongs to a novel class of drugs known as triple agonists , meaning it simultaneously activates three hormone receptors: GLP-1 (glucagon-like peptide-1) which reduces appetite and slows gastric emptying [9] [10] GIP (glucose-dependent insulinotropic polypeptide) which may enhance insulin secretion and has been suggested in early studies to support fat metabolism Glucagon receptor which may increase energy expenditure and has been proposed to support fat breakdown in the liver, based on early pharmacological data [11] [12] This triple mechanism distinguishes retatrutide from existing approved medicines such as semaglutide (a GLP-1 agonist) or tirzepatide (a dual GLP-1/GIP agonist)

Not intended for diagnosis, treatment, cure, or prevention of any disease